PTPRC and myelodysplastic syndrome: In a study of stringently sorted circulating ECs (CD34+/CD45–/CD146+) from MDS patients, FISH confirmed 39–84% of cells to carry identical cytogenetic abnormalities to those characterizing the respective MDS hematopoietic clones (Porta et al., 2008).